Off-Label Use of Rituximab in Refractory Pediatric Rheumatic Diseases: A Single-Center Experience

Pediatric Rheumatology - United Kingdom
doi 10.1186/1546-0096-12-s1-p343
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC